Literature DB >> 23426570

The role of the TLR4 signaling pathway in cognitive deficits following surgery in aged rats.

Yi Wang1, Huijuan He, Dan Li, Wenjing Zhu, Kaiming Duan, Yuan Le, Yan Liao, Yangwen Ou.   

Abstract

Postoperative cognitive dysfunction (POCD), common in elderly patients, refers to a decline in cognitive function following surgery, which may persist or even evolve into Alzheimer's disease (AD). Despite great efforts, the mechanism of POCD remains unclear. In the present study, we tested the hypothesis that Toll-like receptor 4 (TLR4) on microglia contributes to POCD. Shortly after surgery, aged rats demonstrated significant deficits in memory and learning, accompanied by the activation of microglia, marked upregulation of TLR4 on microglia in the hippocampus, as well as an increased expression of two downstream factors [myeloid differentiation factor 88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF)] and pro-inflammatory cytokines [including tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β)]. With an increase in time following surgery, the expression of TLR4 and the aforementioned factors and pro-inflammatory cytokines gradually returned to normal, as did the cognitive function of the aged rats. In conclusion, our study suggests that the activation of TLR4 signaling on microglia may act as an underlying mechanism of POCD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426570     DOI: 10.3892/mmr.2013.1322

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  20 in total

1.  TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Authors:  Kevin G Burfeind; Xinxia Zhu; Peter R Levasseur; Katherine A Michaelis; Mason A Norgard; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2018-05-28       Impact factor: 7.217

2.  The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer's-Related Pathology via HMGB1 Inhibition.

Authors:  Zhong-Hong Kong; Xin Chen; Hui-Po Hua; Liang Liang; Long-Juan Liu
Journal:  J Mol Neurosci       Date:  2017-10-16       Impact factor: 3.444

3.  Amantadine attenuates sepsis-induced cognitive dysfunction possibly not through inhibiting toll-like receptor 2.

Authors:  Wei Xing; Pinjie Huang; Yang Lu; Weian Zeng; Zhiyi Zuo
Journal:  J Mol Med (Berl)       Date:  2018-03-03       Impact factor: 4.599

Review 4.  NLRP3 inflammasomes are involved in the progression of postoperative cognitive dysfunction: from mechanism to treatment.

Authors:  Shuai Zhao; Fan Chen; Dunwei Wang; Wei Han; Yuan Zhang; Qiliang Yin
Journal:  Neurosurg Rev       Date:  2020-09-12       Impact factor: 3.042

Review 5.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 6.  Ketamine and peripheral inflammation.

Authors:  Marc De Kock; Sebastien Loix; Patricia Lavand'homme
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

7.  Toll-like receptor 2 activation and up-regulation by high mobility group box-1 contribute to post-operative neuroinflammation and cognitive dysfunction in mice.

Authors:  Fei Lin; Weiran Shan; Yuxin Zheng; Linghui Pan; Zhiyi Zuo
Journal:  J Neurochem       Date:  2021-05-05       Impact factor: 5.372

Review 8.  Biomarkers of postoperative delirium and cognitive dysfunction.

Authors:  Ganna Androsova; Roland Krause; Georg Winterer; Reinhard Schneider
Journal:  Front Aging Neurosci       Date:  2015-06-09       Impact factor: 5.750

9.  Leptin: new hope for the treatment of post-operative cognitive dysfunction?

Authors:  Fei Hua; Chun Yang; Bin Zhu
Journal:  Med Sci Monit       Date:  2014-05-26

10.  Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.

Authors:  Daniel T Barratt; Pål Klepstad; Ola Dale; Stein Kaasa; Andrew A Somogyi
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.